[1]
2021. The role of EGFR mutation testing in the choice for surgical tactics in NSCLC treatment. Voprosy onkologii. 67, 3 (Jul. 2021), 315–322. DOI:https://doi.org/10.37469/0507-3758-2021-67-3-315-322.